← Eichor
Study identifier: NCT06804434 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management

Condition: Pain · Anesthesia · Perioperative Care  ·  Sponsor: Osoian Cristiana

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This prospective randomised clinical trial aims to assess the impact of intraoperative nociception monitoring using NOL on anesthetic management during major abdominal surgery. Additionally, the study will objectively evaluate using NOL how intravenous lidocaine administration, influences opioid requirements and the effect of this multimodal approach on early postoperative outcomes. The investigators hypothesize that NOL-guided intraoperative opioid administration reduces both intraoperative and postoperative opioid use, positively influencing 24-hour outcomes. Furthermore, the addition of intraoperative lidocaine in NOL-guided analgesia may further decrease opioid consumption.

This description comes directly from the study's public registry record.

Talk to the study team

Cristiana Osoian  ·  +40743352189  ·  osoiancris@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Regional Gastroenterology and Hepatology Institute Octavian FodorCluj-Napoca, Cluj, RomaniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06804434